CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
OTLK Outlook Therapeutics
- 1.560
- +0.080+5.41%
Close Apr 29 16:00 ET
- 1.560
- 0.0000.00%
Post 20:01 ET
50.89MMarket Cap-0.63P/E (TTM)
1.570High1.480Low316.23KVolume1.480Open1.480Pre Close490.25KTurnover1.53%Turnover RatioLossP/E (Static)32.62MShares9.25052wk High-1.01P/B32.35MFloat Cap0.87052wk Low--Dividend TTM20.74MShs Float219.200Historical High--Div YieldTTM6.08%Amplitude0.870Historical Low1.550Avg Price1Lot Size
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Outlook Therapeutics Stock Forum
Major FDA Milestone: Novel Wet AMD Drug Gets Review Date, Could Be First-of-its-Kind Approval
Just
Outlook Therapeutics® Re-Submits Biologics License Application for Ons-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration! Expected decision within 6 Months
Can Outlook's Eye Treatment Win FDA Approval Despite Missing Primary Endpoint?
The Q1 FY2025 results reveal a complex financial situation requiring careful analysis. While the reported $17.4M net income appears positive, the adjusted net loss of $21.6M reflects significant operational costs and excludes non-cash gains from warrant and convertible note valuations. This 16.7% increase in adjusted net loss compared to the previous year ($10.1M) indicates growing operational expenses as the company approaches commercialization....
Outlook Reports Stunning Earnings Turnaround: From $11.2M Loss to $17.4M Profit as European Launch Approaches
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, ...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY,...
Major Clinical Trial Success: Revolutionary Eye Treatment Shows Promise in NORSE EIGHT Study
No comment yet